SAMS Releases Statement on BARDA DRIVe — U.S. Biologic, Inc. Partnership

Washington, DC: Congratulations to SAMS member, US Biologic on their partnership with BARDA to innovate the flu vaccine delivery. This is positive momentum in a story about U.S. government investment in American-made technologies and healthcare access.

We celebrate this announcement with US Biologic and encourage the U.S. government to continue partnering with other American-made companies that provide safe, effective and innovative products that benefit Americans.

Media Contact: